-
1
-
-
84860528205
-
Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate
-
J. Douxfils, F. Mullier, S. Robert, C. Chatelain, B. Chatelain, and J.M. Dogne Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate Thromb. Haemost. 107 2012 985 997 10.1160/TH11-11-0804
-
(2012)
Thromb. Haemost.
, vol.107
, pp. 985-997
-
-
Douxfils, J.1
Mullier, F.2
Robert, S.3
Chatelain, C.4
Chatelain, B.5
Dogne, J.M.6
-
2
-
-
84883238313
-
Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate
-
J. Douxfils, J.M. Dogne, F. Mullier, B. Chatelain, Y. Ronquist-Nii, R.E. Malmstrom, and P. Hjemdahl Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate Thromb. Haemost. 110 2013 543 549 10.1160/TH13-03-0202
-
(2013)
Thromb. Haemost.
, vol.110
, pp. 543-549
-
-
Douxfils, J.1
Dogne, J.M.2
Mullier, F.3
Chatelain, B.4
Ronquist-Nii, Y.5
Malmstrom, R.E.6
Hjemdahl, P.7
-
3
-
-
84891680866
-
Measuring dabigatran concentrations using a chromogenic ecarin clotting time assay
-
R.C. Gosselin, D.M. Dwyre, and W.E. Dager Measuring dabigatran concentrations using a chromogenic ecarin clotting time assay Ann. Pharmacother. 47 2013 1635 1640 10.1177/1060028013509074
-
(2013)
Ann. Pharmacother.
, vol.47
, pp. 1635-1640
-
-
Gosselin, R.C.1
Dwyre, D.M.2
Dager, W.E.3
-
4
-
-
84886792146
-
Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma
-
J.P. Antovic, M. Skeppholm, J. Eintrei, E.E. Boija, L. Soderblom, E.M. Norberg, L. Onelov, Y. Ronquist-Nii, A. Pohanka, O. Beck, P. Hjemdahl, and R.E. Malmstrom Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma Eur. J. Clin. Pharmacol. 69 2013 1875 1881 10.1007/s00228-013-1550-4
-
(2013)
Eur. J. Clin. Pharmacol.
, vol.69
, pp. 1875-1881
-
-
Antovic, J.P.1
Skeppholm, M.2
Eintrei, J.3
Boija, E.E.4
Soderblom, L.5
Norberg, E.M.6
Onelov, L.7
Ronquist-Nii, Y.8
Pohanka, A.9
Beck, O.10
Hjemdahl, P.11
Malmstrom, R.E.12
-
5
-
-
84881605571
-
Performance of coagulation tests in patients on therapeutic doses of dabigatran: A cross-sectional pharmacodynamic study based on peak and trough plasma levels
-
E.M. Hawes, A.M. Deal, D. Funk-Adcock, R. Gosselin, C. Jeanneret, A.M. Cook, J.M. Taylor, H.C. Whinna, A.M. Winkler, and S. Moll Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross-sectional pharmacodynamic study based on peak and trough plasma levels J. Thromb. Haemost. 11 2013 1493 1502 10.1111/jth.12308
-
(2013)
J. Thromb. Haemost.
, vol.11
, pp. 1493-1502
-
-
Hawes, E.M.1
Deal, A.M.2
Funk-Adcock, D.3
Gosselin, R.4
Jeanneret, C.5
Cook, A.M.6
Taylor, J.M.7
Whinna, H.C.8
Winkler, A.M.9
Moll, S.10
-
6
-
-
84930187338
-
Estimation of dabigatran plasma concentrations in the perioperative setting. An ex vivo study using dedicated coagulation assays
-
J. Douxfils, S. Lessire, A.S. Dincq, P. Hjemdahl, Y. Ronquist-Nii, A. Pohanka, M. Gourdin, B. Chatelain, J.M. Dogne, and F. Mullier Estimation of dabigatran plasma concentrations in the perioperative setting. An ex vivo study using dedicated coagulation assays Thromb. Haemost. 113 2014 10.1160/TH14-09-0808
-
(2014)
Thromb. Haemost.
, vol.113
-
-
Douxfils, J.1
Lessire, S.2
Dincq, A.S.3
Hjemdahl, P.4
Ronquist-Nii, Y.5
Pohanka, A.6
Gourdin, M.7
Chatelain, B.8
Dogne, J.M.9
Mullier, F.10
-
7
-
-
84905019610
-
Dabigatran assessment in patients with acute complications using routine coagulation assays
-
L. Stang, S. Nahirniak, K. Butcher, and A.J. Szkotak Dabigatran assessment in patients with acute complications using routine coagulation assays Blood Coagul. Fibrinolysis 25 2014 426 434 10.1097/MBC.0000000000000056
-
(2014)
Blood Coagul. Fibrinolysis
, vol.25
, pp. 426-434
-
-
Stang, L.1
Nahirniak, S.2
Butcher, K.3
Szkotak, A.J.4
-
8
-
-
84880798450
-
The effect of dabigatran on the activated partial thromboplastin time and thrombin time as determined by the Hemoclot thrombin inhibitor assay in patient plasma samples
-
G. Hapgood, J. Butler, E. Malan, S. Chunilal, and H. Tran The effect of dabigatran on the activated partial thromboplastin time and thrombin time as determined by the Hemoclot thrombin inhibitor assay in patient plasma samples Thromb. Haemost. 110 2013 308 315 10.1160/TH13-04-0301
-
(2013)
Thromb. Haemost.
, vol.110
, pp. 308-315
-
-
Hapgood, G.1
Butler, J.2
Malan, E.3
Chunilal, S.4
Tran, H.5
-
9
-
-
84922394366
-
Laboratory measurement of the anticoagulant activity of the non-Vitamin K oral anticoagulants
-
A. Cuker, D.M. Siegal, M.A. Crowther, and D.A. Garcia Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants J. Am. Coll. Cardiol. 64 2014 1128 1139 10.1016/j.jacc.2014.05.065
-
(2014)
J. Am. Coll. Cardiol.
, vol.64
, pp. 1128-1139
-
-
Cuker, A.1
Siegal, D.M.2
Crowther, M.A.3
Garcia, D.A.4
-
10
-
-
77953168824
-
Dabigatran etexilate - A novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
-
J. van Ryn, J. Stangier, S. Haertter, K.H. Liesenfeld, W. Wienen, M. Feuring, and A. Clemens Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity Thromb. Haemost. 103 2010 1116 1127 10.1160/TH09-11-0758
-
(2010)
Thromb. Haemost.
, vol.103
, pp. 1116-1127
-
-
Van Ryn, J.1
Stangier, J.2
Haertter, S.3
Liesenfeld, K.H.4
Wienen, W.5
Feuring, M.6
Clemens, A.7
-
12
-
-
84896717555
-
Validation of hemostasis and coagulation assays: Recommendations and guidelines
-
R.A. Marlar, J.N. Gausman, and J.W. Engel Validation of hemostasis and coagulation assays: recommendations and guidelines Semin. Thromb. Hemost. 40 2014 186 194 10.1055/s-0033-1364186
-
(2014)
Semin. Thromb. Hemost.
, vol.40
, pp. 186-194
-
-
Marlar, R.A.1
Gausman, J.N.2
Engel, J.W.3
-
13
-
-
84886962827
-
Initial evaluation of hemostasis: Reagent and method selection
-
S. Kitchen, J. Olson, F. Prestion
-
W. Chandler Initial evaluation of hemostasis: reagent and method selection S. Kitchen, J. Olson, F. Prestion, Quality in Laboratory Hemostasis and Thrombosis 2013 95 104
-
(2013)
Quality in Laboratory Hemostasis and Thrombosis
, pp. 95-104
-
-
Chandler, W.1
-
14
-
-
84880571372
-
Working Group on Perioperative H. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the working group on perioperative haemostasis (GIHP) - March 2013
-
G. Pernod, P. Albaladejo, A. Godier, C.M. Samama, S. Susen, Y. Gruel, N. Blais, P. Fontana, A. Cohen, J.V. Llau, N. Rosencher, J.F. Schved, E. de Maistre, M.M. Samama, P. Mismetti, and P. Sie Working Group on Perioperative H. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013 Arch. Cardiovasc. Dis. 106 2013 382 393 10.1016/j.acvd.2013.04.009
-
(2013)
Arch. Cardiovasc. Dis.
, vol.106
, pp. 382-393
-
-
Pernod, G.1
Albaladejo, P.2
Godier, A.3
Samama, C.M.4
Susen, S.5
Gruel, Y.6
Blais, N.7
Fontana, P.8
Cohen, A.9
Llau, J.V.10
Rosencher, N.11
Schved, J.F.12
De Maistre, E.13
Samama, M.M.14
Mismetti, P.15
Sie, P.16
-
15
-
-
84940444745
-
-
European Medicines Agency C. Pradaxa - EMEA/H/C/000829/X/13/G. (CHMP) CfMPfHU, 2011.
-
European Medicines Agency C. Pradaxa - EMEA/H/C/000829/X/13/G. (CHMP) CfMPfHU, 2011.
-
-
-
-
16
-
-
84893160985
-
The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)
-
P.A. Reilly, T. Lehr, S. Haertter, S.J. Connolly, S. Yusuf, J.W. Eikelboom, M.D. Ezekowitz, G. Nehmiz, S. Wang, L. Wallentin, and R.-L. Investigators The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy) J. Am. Coll. Cardiol. 63 2014 321 328 10.1016/j.jacc.2013.07.104
-
(2014)
J. Am. Coll. Cardiol.
, vol.63
, pp. 321-328
-
-
Reilly, P.A.1
Lehr, T.2
Haertter, S.3
Connolly, S.J.4
Yusuf, S.5
Eikelboom, J.W.6
Ezekowitz, M.D.7
Nehmiz, G.8
Wang, S.9
Wallentin, L.10
Investigators, R.-L.11
-
17
-
-
0038353977
-
Kitchen S, Machin SJ, Lowe GD, Haemostasis, Thrombosis Task Force of the British Committee for Standards in H. Guidelines on fibrinogen assays
-
I.J. Mackie Kitchen S, Machin SJ, Lowe GD, Haemostasis, Thrombosis Task Force of the British Committee for Standards in H. Guidelines on fibrinogen assays Br. J. Haematol. 121 2003 396 404
-
(2003)
Br. J. Haematol.
, vol.121
, pp. 396-404
-
-
Mackie, I.J.1
-
18
-
-
84864229033
-
External quality assurance of fibrinogen assays using normal plasma: Results of the 2008 College of American Pathologists proficiency testing program in coagulation
-
M.T. Cunningham, J.D. Olson, W.L. Chandler, E.M. Van Cott, C.S. Eby, J. Teruya, S.C. Hollensead, D.M. Adcock, P.M. Allison, K.K. Kottke-Marchant, and M.D. Smith External quality assurance of fibrinogen assays using normal plasma: results of the 2008 College of American Pathologists proficiency testing program in coagulation Arch. Pathol. Lab. Med. 136 2012 789 795 10.5858/arpa.2011-0322-OA
-
(2012)
Arch. Pathol. Lab. Med.
, vol.136
, pp. 789-795
-
-
Cunningham, M.T.1
Olson, J.D.2
Chandler, W.L.3
Van Cott, E.M.4
Eby, C.S.5
Teruya, J.6
Hollensead, S.C.7
Adcock, D.M.8
Allison, P.M.9
Kottke-Marchant, K.K.10
Smith, M.D.11
-
19
-
-
84877117204
-
Thrombin clotting time
-
V. Ignjatovic Thrombin clotting time Methods Mol. Biol. 992 2013 131 138 10.1007/978[--]1-62703-339-8-10
-
(2013)
Methods Mol. Biol.
, vol.992
, pp. 131-138
-
-
Ignjatovic, V.1
-
20
-
-
80052495398
-
Toward development of a point-of-care assay of enoxaparin anticoagulant activity in whole blood
-
M.A. Inchiosa Jr., S. Pothula, K. Kubal, V.T. Sanchala, and I. Navarro Toward development of a point-of-care assay of enoxaparin anticoagulant activity in whole blood J. Thromb. Thrombolysis 32 2011 47 53 10.1007/s11239-010-0546-5
-
(2011)
J. Thromb. Thrombolysis
, vol.32
, pp. 47-53
-
-
Inchiosa, M.A.1
Pothula, S.2
Kubal, K.3
Sanchala, V.T.4
Navarro, I.5
-
21
-
-
84904368894
-
A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time
-
P.K. Chin, D.F. Wright, D.M. Patterson, M.P. Doogue, and E.J. Begg A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time Br. J. Clin. Pharmacol. 78 2014 599 609 10.1111/bcp.12364
-
(2014)
Br. J. Clin. Pharmacol.
, vol.78
, pp. 599-609
-
-
Chin, P.K.1
Wright, D.F.2
Patterson, D.M.3
Doogue, M.P.4
Begg, E.J.5
-
22
-
-
84937250263
-
Dose tailoring of dabigatran etexilate: Obvious or excessive?
-
J. Douxfils, F. Mullier, and J.M. Dogne Dose tailoring of dabigatran etexilate: obvious or excessive? Expert Opin. Drug Saf. 1-7 2015 10.1517/14740338.2015.1049995
-
(2015)
Expert Opin. Drug Saf.
, vol.1-7
-
-
Douxfils, J.1
Mullier, F.2
Dogne, J.M.3
|